全球化学品在线数据库
| CAS 登录号 | 产品名称 | 分子式 |
|---|---|---|
| 1407997-80-1 | (R)-1-Boc-pyrrolidine-3-carboxylic acid hydrazide;tert-butyl (3R)-3-(hydrazinecarbonyl)pyrrolidine-1-carboxylate | C10H19N3O3 |
| 1408058-12-7 | 4-Methoxy-2-(trifluoromethyl)benzenecarboximidamide hydrochloride (1:1) | C9H9F3N2O.HCl |
| 1408058-14-9 | 5-(Chlorosulfonyl)pentanoic acid methyl ester | C6H11ClO4S |
| 1408064-71-0 | 3-[[4-(Dimethylamino)-1-oxo-2-buten-1-yl]amino]-N-[4-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide;JNK-IN-7 | C28H27N7O2 |
| 1408074-42-9 | 5-((tert-Butoxycarbonyl)amino)tetrahydro-2H-pyran-2-carboxylic Acid | C11H19NO5 |
| 1408074-48-5 | 8-Oxa-2-azaspiro[4.5]decane hydrochloride (1:1) | C8H15NO.HCl |
| 1408074-83-8 | Tert-butyl 4-amino-3,3-difluoropyrrolidine-1-carboxylate | C9H16F2N2O2 |
| 1408075-19-3 | 7-Amino-2-azaspiro[3.5]nonane-2-carboxylic acid 1,1-dimethylethyl ester | C13H24N2O2 |
| 1408075-88-6 | 1-Methyl-3-oxocyclobutanecarboxylic acid methyl ester;Methyl 1-methyl-3-oxocyclobutanecarboxylate | C7H10O3 |
| 1408075-90-0 | 7-Oxo-5-oxa-2-azaspiro[3.4]octane-2-carboxylic acid 1,1-dimethylethyl ester | C11H17NO4 |
| 1408075-99-9 | trans-3-Fluorocyclobutanamine hydrochloride (1:1) | C4H8FN.HCl |
| 1408076-03-8 | 3,3-Difluoro-1-methylcyclobutanamine | C5H9F2N |
| 1408076-07-2 | 2,5-Diazaspiro[3.5]nonane-5-carboxylic acid 1,1-dimethylethyl ester ethanedioate (1:1) | C12H22N2O2.C2H2O4 |
| 1408077-50-8 | Dapagliflozin Impurity 61;4-Chloro-3-(4-ethoxybenzyl)phenol | C15H15ClO2 |
| 1408238-36-7 | Ethyl 2-[[[4-[[[(hexyloxy)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazole-5-carboxylate | C26H33N5O4 |
| 1408238-41-4 | 2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazole-5-carboxylic acid ethyl ester | C19H21N5O2 |
| 1408282-25-6 | 3-[2-(1,3-Dihydro-1,3-dioxo-2H-isoindol-2-yl)ethyl]-6-fluoro-1H-indole-4-carboxylic acid methyl ester | C20H15FN2O4 |
| 1408282-26-7 | 8-Fluoro-1,3,4,5-tetrahydro-6H-pyrrolo[4,3,2-ef][2]benzazepin-6-one | C11H9FN2O |
| 1410783-24-2 | 5-(tert-Butyl)-[1,1'-biphenyl]-2-amine;4-tert-butyl-2-phenylaniline | C16H19N |
| 1410880-22-6 | 3-[[4-(Dimethylamino)-1-oxo-2-buten-1-yl]amino]-N-[3-methyl-4-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide;JNK Inhibitor XVI | C29H29N7O2 |
| 1412427-05-4 | 2-Amino-2'-C-methyladenosine 2',3',5'-tribenzoate | C32H28N6O7 |
| 1412439-84-9 | (11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-bis(4-nitrophenyl)-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-oxide | C29H21N2O8P |
| 1412898-66-8 | Docetaxel Impurity 19;2-Debenzoyl-2-pentenoyl Docetaxel | C41H55NO14 |
| 1413367-76-6 | (3R,5S)-rel-3-Amino-5-methyl-1-piperidinecarboxylic acid 1,1-dimethylethyl ester | C11H22N2O2 |
| 1413732-47-4 | Copper(1+) trifluoromethanethiolate - 2,2'-bipyridine (1:1:1) | C11H8CuF3N2S |
| 1414378-14-5 | 3-[5-(3,5-Dichloro-4-fluorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-5,6-dihydro-4H-cyclopenta[c]thiophene-1-carboxylic acid methyl ester | C19H13Cl2F4NO3S |
| 1414469-59-2 | 2,2',2'-[1,3,5-Triazine-2,4,6-triyltris(oxy-4,1-phenylenecarbonyloxy)]tris[N,N,N-trimethylethanaminium] iodide (1:3) | C39H51N6O9.I3 |
| 1414642-43-5 | 2-Amino-N-(2,2-difluoroethyl)acetamide hydrochloride (1:1) | C4H8F2N2O.HCl |
| 1414933-80-4 | Ritonavir EP Impurity R;Thiazol-5-ylmethyl (2S,3S,5R)-3-hydroxy-5-((S)-2-(3-((2-isopropylthiazol-4-yl)methyl)-3-methylureido(-3-methylbutanamido)-1,6-diphenylhexan-2-ylcarbamate | C37H48N6O5S2 |
| 1414956-67-4 | 7-Bromo-4(1H)-cinnolinone | C8H5BrN2O |
| 1414960-66-9 | (2S)-3-Butyn-2-amine hydrochloride | C4H7N.HCl |
| 1414973-10-6 | B-[2-(Hydroxymethyl)-4-pyridinyl]-boronic Acid | C6H8BNO3 |
| 1415089-89-2 | Methyl 5-cyano-2-(trifluoromethyl)benzoate | C10H6F3NO2 |
| 1415238-25-3 | 1,3,6,8-Tetrakis(4-formylphenyl)pyrene | C44H26O4 |
| 1415238-77-5 | 1H-Imidazol-1-yl(2-methyl-3-furanyl)methanone | C9H8N2O2 |
| 1415334-59-6 | (10-[1,1':3',1''-Terphenyl]-5'-yl-9-anthracenyl)boronic acid | C32H23BO2 |
| 1415477-23-4 | 4-Bromo-7-chloro-6-[(4-cyclopropylphenyl)methyl]-2,3-dihydrobenzofuran | C18H16BrClO |
| 1415559-43-1 | N-[5-[[6-[3-(1,3-Dioxoisoindol-2-yl)phenyl]pyrimidin-4-yl]amino]-2-methylphenyl]methanesulfonamide;CDK9 inhibitor | C26H21N5O4S |
| 1415560-64-3 | GSK256066 trifluoroacetate;6-[[3-[(Dimethylamino)carbonyl]phenyl]sulfonyl]-4-[(3-methoxyphenyl)amino]-8-methyl-3-quinolinecarboxamide 2,2,2-trifluoroacetate (1:1) | C27H26N4O5S.C2HF3O2 |
| 1415560-69-8 | 3-[(1R)-1-(2,6-Dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl]-2-pyridinamine hydrochloride | C21H22Cl2FN5O.HCl |
| 1415562-82-1 | (2R)-1-[[4-[[3-Methyl-5-[(phenylsulfonyl)methyl]phenoxy]methyl]phenyl]methyl]-2-pyrrolidinemethanol | C27H31NO4S |
| 1415566-28-7 | N-[[(5S)-2-Oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-2-thiophenecarboxamide | C19H19N3O5S |
| 1415716-58-3 | (2E)-N-[2-[2-(Trifluoromethyl)-1H-indol-1-yl]ethyl]-3-(3,4,5-trimethoxyphenyl)-2-propenamide | C23H23F3N2O4 |
| 1415761-37-3 | 5,8-Dibromodithieno[3',2':3,4;2'',3'':5,6]benzo[1,2-c][1,2,5]thiadiazole | C10H2Br2N2S3 |
| 1415795-50-4 | Angustin A;1,8-Dihydroxy-2,3,5-trimethoxy-9H-xanthen-9-one | C16H14O7 |
| 1415795-51-5 | Angustin B;8-Hydroxy-1,2,3,5-tetramethoxy-9H-xanthen-9-one | C17H16O7 |
| 1415800-43-9 | 1,1'-[2-(Phenylamino)-1,4-phenylene]bis[1-[4-(1-pyrrolidinyl)-1-piperidinyl]methanone];UNC 1215 | C32H43N5O2 |
| 1415824-87-1 | Tert-butyl 4-(((6-amino-5-(4-phenoxyphenyl)pyrimidin-4-yl)amino)methyl)piperidine-1-carboxylate | C27H33N5O3 |
| 1415929-80-4 | Poly[[4,8-bis[5-(2-ethylhexyl)-2-thienyl]benzo[1,2-b:4,5-b']dithiophene-2,6-diyl]-2,5-thiophenediyl[5,7-bis(2-ethylhexyl)-4,8-dioxo-4H,8H-benzo[1,2-c:4,5-c']dithiophene-1,3-diyl]] | |
| 1415964-02-1 | (1S,2R)-2-[[(1,1-Dimethylethoxy)carbonyl]amino]cyclopropanecarboxylic acid | C9H15NO4 |